- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT00287092 | Completed | Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
807 | All | 80 Days to 120 Days (Child) | NCT00287092 | A5I15 | February 2006 | May 2007 | September 2008 | February 6, 2006 | January 7, 2015 |
|